These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9108859)
1. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. Christou H; Adatia I; Van Marter LJ; Kane JW; Thompson JE; Stark AR; Wessel DL; Kourembanas S J Pediatr; 1997 Apr; 130(4):603-11. PubMed ID: 9108859 [TBL] [Abstract][Full Text] [Related]
2. Plasma cyclic guanosine monophosphate reflecting the severity of persistent pulmonary hypertension of the newborn. Turanlahti M; Pesonen E; Pohjavuori M; Lassus P; Fyhrquist F; Andersson S Biol Neonate; 2001 Aug; 80(2):107-12. PubMed ID: 11509809 [TBL] [Abstract][Full Text] [Related]
3. Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants. Truog WE; Pallotto E; Clark P; Banks B; Kaftan HA; Ekekezie II; Norberg M; Ballard RA Clin Sci (Lond); 2002 Aug; 103 Suppl 48():294S-297S. PubMed ID: 12193107 [TBL] [Abstract][Full Text] [Related]
4. Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn. Endo A; Ayusawa M; Minato M; Takada M; Takahashi S; Harada K Eur J Pediatr; 2001 Apr; 160(4):217-22. PubMed ID: 11317642 [TBL] [Abstract][Full Text] [Related]
5. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Kumar P; Kazzi NJ; Shankaran S Am J Perinatol; 1996 Aug; 13(6):335-41. PubMed ID: 8865978 [TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide in the management of persistent pulmonary hypertension of term infants. Chen JY; Su PH; Chen FL; Lee HS J Formos Med Assoc; 2001 Oct; 100(10):703-6. PubMed ID: 11760378 [TBL] [Abstract][Full Text] [Related]
7. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Cornfield DN; Maynard RC; deRegnier RA; Guiang SF; Barbato JE; Milla CE Pediatrics; 1999 Nov; 104(5 Pt 1):1089-94. PubMed ID: 10545552 [TBL] [Abstract][Full Text] [Related]
9. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Kinsella JP; Neish SR; Shaffer E; Abman SH Lancet; 1992 Oct; 340(8823):819-20. PubMed ID: 1357246 [TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn: four-year experience in a single medical center. Su BH; Lin TW; Lin HC; Tsai FJ; Peng CT Acta Paediatr Taiwan; 2002; 43(5):259-64. PubMed ID: 12607481 [TBL] [Abstract][Full Text] [Related]
11. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. Kinsella JP; Neish SR; Ivy DD; Shaffer E; Abman SH J Pediatr; 1993 Jul; 123(1):103-8. PubMed ID: 8320602 [TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Davidson D; Barefield ES; Kattwinkel J; Dudell G; Damask M; Straube R; Rhines J; Chang CT Pediatrics; 1998 Mar; 101(3 Pt 1):325-34. PubMed ID: 9480993 [TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infants with persistent pulmonary hypertension of the newborn. Hosono S; Ohno T; Kimoto H; Shimizu M; Takahashi S; Harada K J Perinat Med; 2006; 34(4):333-7. PubMed ID: 16856826 [TBL] [Abstract][Full Text] [Related]
14. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. Kinsella JP; Truog WE; Walsh WF; Goldberg RN; Bancalari E; Mayock DE; Redding GJ; deLemos RA; Sardesai S; McCurnin DC; Moreland SG; Cutter GR; Abman SH J Pediatr; 1997 Jul; 131(1 Pt 1):55-62. PubMed ID: 9255192 [TBL] [Abstract][Full Text] [Related]
15. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Farrow KN; Lakshminrusimha S; Czech L; Groh BS; Gugino SF; Davis JM; Russell JA; Steinhorn RH Am J Physiol Lung Cell Mol Physiol; 2010 Jul; 299(1):L109-16. PubMed ID: 20400523 [TBL] [Abstract][Full Text] [Related]
16. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment. Steinhorn RH; Millard SL; Morin FC Clin Perinatol; 1995 Jun; 22(2):405-28. PubMed ID: 7671545 [TBL] [Abstract][Full Text] [Related]
17. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Wessel DL; Adatia I; Van Marter LJ; Thompson JE; Kane JW; Stark AR; Kourembanas S Pediatrics; 1997 Nov; 100(5):E7. PubMed ID: 9347001 [TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension. Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB J Pediatr; 2012 Jan; 160(1):111-5.e1. PubMed ID: 21839472 [TBL] [Abstract][Full Text] [Related]